Table 1.
Availability of all the DM and CVD medicines and diagnostic tests in all the study sites
Medicines (N = 21 classes) | Availability (%) | Diagnostic tests (N = 19) | Availability (%) |
---|---|---|---|
UFH | 20.1 | Microalbuminuria | 6.8 |
Isosorbide mono nitrate | 27.8 | Serum ketones | 11.4 |
LMWH | 31.9 | Serum natriuretic peptides | 11.4 |
Intermediate insulin | 34.7 | Echocardiography | 34.1 |
Hydralazine | 47.2 | Coagulation profile | 36.4 |
Pre mixed insulin | 60.1 | Serum troponin testing | 43.2 |
Warfarin | 64.6 | HbA1c testing | 43.2 |
Soluble insulin | 68.8 | Thyroid function tests | 43.2 |
ARB-thiazide diuretics | 82.6 | Electrocardiography | 54.6 |
Digoxin | 84.0 | Uric acid testing | 56.8 |
Statins | 84.0 | Lipid profile | 65.9 |
ARB | 86.8 | Creatinine | 86.4 |
Spironolactone | 87.5 | Urea | 86.4 |
Benzathine penicillin | 87.5 | Serum electrolytes | 88.6 |
Furosemide | 89.6 | Chest X-ray | 88.6 |
Thiazide diuretics | 94.4 | Liver function tests | 95.5 |
Anti platelet drugs | 95.1 | Glucometers | 97.7 |
ACEI | 96.5 | CBC testing | 97.7 |
Beta blockers | 97.2 | Urinalysis | 100 |
CCB | 99.3 | ||
OHA | 100 |
UFH Unfractionated heparin, LMWH Low molecular weight heparin, ARB Angiotensin II receptor blockers, ACEI Angiotensin converting enzyme inhibitors, CCB Calcium channel blockers, OHA Oral hypoglycaemic agents, HbA1c Glycated haemoglobin